Detalles de la búsqueda
1.
A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.
Dig Dis Sci
; 66(11): 3676-3688, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410573
2.
Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever.
Clin Transplant
; 32(8): e13345, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29981275
3.
Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Cognitive Impairment and All-Cause Dementia: A Comprehensive Review.
Turk J Gastroenterol
; 35(2): 76-82, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454238
4.
Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease Cross Talk.
Adv Kidney Dis Health
; 30(4): 315-335, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37657879
5.
Prevalence of metabolic dysfunction-associated fatty liver disease in kidney transplant recipients: A cross-sectional study using FibroScan.
Hepatol Forum
; 4(1): 14-18, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843889
6.
Changes in the etiology of chronic liver disease by referral to a FibroScan center: Increasing prevalence of the nonalcoholic fatty liver disease.
Hepatol Forum
; 4(1): 7-13, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843891
7.
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
J Clin Transl Hepatol
; 10(2): 329-338, 2022 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35528971
8.
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.
Ther Adv Endocrinol Metab
; 13: 20420188221139650, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36533185
9.
Prevention of hepatocellular carcinoma and monitoring of high-risk patients.
Hepatol Forum
; 3(1): 33-38, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35782375
10.
Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index: failure in the prediction of advanced fibrosis in lean and morbidly obese individuals.
Eur J Gastroenterol Hepatol
; 34(1): 98-103, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32976186
11.
The Effect of Plant Metabolites on Coronaviruses: A Comprehensive Review Focusing on their IC50 Values and Molecular Docking Scores.
Mini Rev Med Chem
; 22(3): 457-483, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34488609
12.
Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic.
Turk J Gastroenterol
; 32(5): 466-472, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34231477
13.
Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids.
Eur J Gastroenterol Hepatol
; 33(1S Suppl 1): e390-e394, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33731597
14.
Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease.
Hepatol Forum
; 2(3): 97-101, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35784903
15.
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
Hepatol Forum
; 2(2): 37-42, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35783905
16.
The utility of noninvasive scores in non-alcoholic fatty liver disease patients with normal and elevated serum transaminases.
Hepatol Forum
; 1(1): 8-13, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949666
17.
Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients.
Eur J Gastroenterol Hepatol
; 32(10): 1352-1357, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32092046
18.
Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease.
Acta Diabetol
; 57(5): 613-618, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897769
19.
The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study.
Eur J Gastroenterol Hepatol
; 32(5): 642-649, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31651653
20.
The comparison of resting metabolic rate between biopsy-proven non-alcoholic steatohepatitis and non-alcoholic fatty liver patients.
Hepatol Forum
; 1(1): 14-19, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35949663